SCHEDULE 14A

Company

Lexaria Bioscience Corp.

Filed

March 28, 2012

Period of Report

April 30, 2012

Accession Number

0001204459-12-000624

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →